Metabolic dysfunction-associated fatty liver disease and liver fibrosis score in patients with COVID-19 as predictors of adverse clinical outcomes: an artificial intelligent application through machine learning

Detalles Bibliográficos
Autores principales: Dalbeni, A., Zoncapè, M., Carlin, M., Bicego, M., Simonetti, A., Ceruti, V., Mantovani, A., Inglese, F., Zamboni, G., Sartorio, A., Minuz, P., Romano, S., Crisafulli, E., Fava, C., Sacerdoti, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
P-11
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935166/
http://dx.doi.org/10.1016/j.dld.2022.01.045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935166/
http://dx.doi.org/10.1016/j.dld.2022.01.045

Ejemplares similares